160 related articles for article (PubMed ID: 19418268)
1. Decline in daily running distance presages disease onset in a mouse model of ALS.
Bruestle DA; Cutler RG; Telljohann RS; Mattson MP
Neuromolecular Med; 2009; 11(2):58-62. PubMed ID: 19418268
[TBL] [Abstract][Full Text] [Related]
2. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
3. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
4. Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.
Deitch JS; Alexander GM; Bensinger A; Yang S; Jiang JT; Heiman-Patterson TD
PLoS One; 2014; 9(6):e99879. PubMed ID: 24945277
[TBL] [Abstract][Full Text] [Related]
5. Early detection of motor dysfunction in the SOD1G93A mouse model of Amyotrophic Lateral Sclerosis (ALS) using home cage running wheels.
Bennett EJ; Mead RJ; Azzouz M; Shaw PJ; Grierson AJ
PLoS One; 2014; 9(9):e107918. PubMed ID: 25268710
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis.
Stam NC; Nithianantharajah J; Howard ML; Atkin JD; Cheema SS; Hannan AJ
Eur J Neurosci; 2008 Aug; 28(4):717-23. PubMed ID: 18702691
[TBL] [Abstract][Full Text] [Related]
7. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
8. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
Turner BJ; Ackerley S; Davies KE; Talbot K
Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
[TBL] [Abstract][Full Text] [Related]
9. Extensive exercise is not harmful in amyotrophic lateral sclerosis.
Liebetanz D; Hagemann K; von Lewinski F; Kahler E; Paulus W
Eur J Neurosci; 2004 Dec; 20(11):3115-20. PubMed ID: 15579165
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
11. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
12. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
13. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
14. Moderate exercise delays the motor performance decline in a transgenic model of ALS.
Carreras I; Yuruker S; Aytan N; Hossain L; Choi JK; Jenkins BG; Kowall NW; Dedeoglu A
Brain Res; 2010 Feb; 1313():192-201. PubMed ID: 19968977
[TBL] [Abstract][Full Text] [Related]
15. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
16. A study of the purine derivative AIT-082 in G93A SOD1 transgenic mice.
Jiang F; Li WP; Kwiecien J; Turnbull J
Int J Immunopathol Pharmacol; 2006; 19(3):489-98. PubMed ID: 17026833
[TBL] [Abstract][Full Text] [Related]
17. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.
Hayworth CR; Gonzalez-Lima F
Neuroscience; 2009 Dec; 164(3):975-85. PubMed ID: 19699279
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N
Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
[TBL] [Abstract][Full Text] [Related]
20. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
